In memoriam: Joel S. Bennett
, a blood researcher at the University of Pennsylvania, died June 21, of pancreatic cancer. He was 78.
Bennet was born in 1942 to Marvin and Rhoda Bennett and grew up in Southfield, Michigan. He graduated from the University of Michigan with a premed bachelor’s degree in 1963 and a medical degree from the University of Michigan Medical School in 1967.

After earning his M.D., Bennett went to University of Pennsylvania for a residency in internal medicine and a fellowship in hematology–oncology. Outside of briefly serving as a physician in the U.S. Air Force, Bennett remained a member of Penn’s medical and academic community for over 40 years.
Bennett’s research focused on understanding the biophysical and molecular interactions of tiny blood cells called platelets. He was the first to discover that a protein produced by the liver called fibrinogen binds platelets. This binding results in clumping and accumulation of platelets that is important for clotting and can play a role in heart attacks or strokes.
This discovery and Bennett’s other research into platelet biology contributed to the development of drugs that block platelet aggregation, commonly known as blood thinners. Today these drugs are critical to preventing blood clots in certain at-risk patients.
Bennett received various awards in recognition of his work, including the Ernest Beutler Prize from the American Society of Hematology, the society’s highest honor. He was also recognized by the Association of American Physicians and the American Society for Clinical Investigation.
According to in The Philadelphia Inquirer, Bennett is remembered by his colleagues for his scientific acumen, devotion to his patients and dedication as an educator.
Bennett is survived by his wife, Evelyn; three sons, Joe, David and Andrew Bennett; two daughters, Lisa Bennett and Lisa Dunn; a brother and sister; and nine grandchildren.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Meet the 2025 SOC grant awardees
Five science outreach and communication projects received up to $1,000 from ASBMB to promote the understanding of molecular life science.

Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

In memoriam: William S. Sly
He served on the 鶹ýɫƬ and 鶹ýɫƬ Biology Council in 2005 and 2006 and was an ASBMB member for 35 years.

ASBMB committees welcome new members
Members joined these committees: Education and Professional Development, Maximizing Access, Meetings, 鶹ýɫƬ, Public Affairs Advisory, Science Outreach and Communication, Student Chapters and Women in Biochemistry and 鶹ýɫƬ Biology.